Glenn J. Rapsinski

781 total citations
19 papers, 614 citations indexed

About

Glenn J. Rapsinski is a scholar working on Molecular Biology, Endocrinology and Infectious Diseases. According to data from OpenAlex, Glenn J. Rapsinski has authored 19 papers receiving a total of 614 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Endocrinology and 4 papers in Infectious Diseases. Recurrent topics in Glenn J. Rapsinski's work include Gut microbiota and health (5 papers), Cystic Fibrosis Research Advances (4 papers) and Escherichia coli research studies (4 papers). Glenn J. Rapsinski is often cited by papers focused on Gut microbiota and health (5 papers), Cystic Fibrosis Research Advances (4 papers) and Escherichia coli research studies (4 papers). Glenn J. Rapsinski collaborates with scholars based in United States and Netherlands. Glenn J. Rapsinski's co-authors include Çağla Tükel, Gertrude O. Oppong, R. Paul Wilson, Tiffanny Newman, Mark Goulian, Sarah A. Tursi, Bettina A. Buttaro, Paul M. Gallo, Uma Sriram and Stefania Gallucci and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Immunity.

In The Last Decade

Glenn J. Rapsinski

16 papers receiving 603 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Glenn J. Rapsinski United States 11 338 131 119 105 79 19 614
Gertrude O. Oppong United States 6 318 0.9× 127 1.0× 102 0.9× 100 1.0× 66 0.8× 7 509
Sarah A. Tursi United States 12 364 1.1× 104 0.8× 110 0.9× 118 1.1× 97 1.2× 15 563
Azadeh Saffarian France 8 424 1.3× 121 0.9× 70 0.6× 93 0.9× 117 1.5× 13 683
Sébastien Massier France 11 399 1.2× 131 1.0× 56 0.5× 72 0.7× 81 1.0× 17 646
Mehri Zareie Canada 11 336 1.0× 76 0.6× 157 1.3× 134 1.3× 36 0.5× 11 727
David Prescott Canada 14 445 1.3× 133 1.0× 261 2.2× 71 0.7× 33 0.4× 21 811
Ulrike Dringenberg Germany 5 312 0.9× 92 0.7× 65 0.5× 135 1.3× 27 0.3× 6 559
Ava Behrouzi Iran 16 679 2.0× 171 1.3× 67 0.6× 123 1.2× 27 0.3× 47 949
Xiangyu Mou China 12 326 1.0× 38 0.3× 106 0.9× 56 0.5× 79 1.0× 28 539
Kelly Schwartz United States 6 525 1.6× 190 1.5× 32 0.3× 45 0.4× 53 0.7× 7 669

Countries citing papers authored by Glenn J. Rapsinski

Since Specialization
Citations

This map shows the geographic impact of Glenn J. Rapsinski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Glenn J. Rapsinski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Glenn J. Rapsinski more than expected).

Fields of papers citing papers by Glenn J. Rapsinski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Glenn J. Rapsinski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Glenn J. Rapsinski. The network helps show where Glenn J. Rapsinski may publish in the future.

Co-authorship network of co-authors of Glenn J. Rapsinski

This figure shows the co-authorship network connecting the top 25 collaborators of Glenn J. Rapsinski. A scholar is included among the top collaborators of Glenn J. Rapsinski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Glenn J. Rapsinski. Glenn J. Rapsinski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Rapsinski, Glenn J., et al.. (2025). Mutations leading to ceftolozane/tazobactam and imipenem/cilastatin/relebactam resistance during in vivo exposure to ceftazidime/avibactam in Pseudomonas aeruginosa. Microbiology Spectrum. 13(3). e0231224–e0231224. 2 indexed citations
2.
Armbruster, Catherine R., Glenn J. Rapsinski, Monika Johnson, et al.. (2025). Respiratory viral infection is associated with increased pseudomonas abundance in the cystic fibrosis airway. ERJ Open Research. 1022–2025.
3.
Rapsinski, Glenn J., et al.. (2024). Pseudomonas aeruginosa senses and responds to epithelial potassium flux via Kdp operon to promote biofilm. PLoS Pathogens. 20(5). e1011453–e1011453.
4.
Armbruster, Catherine R., Glenn J. Rapsinski, C. W. Marshall, et al.. (2024). Cystic fibrosis pathogens persist in the upper respiratory tract following initiation of elexacaftor/tezacaftor/ivacaftor therapy. Microbiology Spectrum. 12(8). e0078724–e0078724. 8 indexed citations
5.
Armbruster, Catherine R., Glenn J. Rapsinski, Jordan R. Gaston, et al.. (2024). Effects of highly effective modulator therapy on the dynamics of the respiratory mucosal environment and inflammatory response in cystic fibrosis. Pediatric Pulmonology. 59(5). 1266–1273. 10 indexed citations
6.
Rapsinski, Glenn J., et al.. (2023). Do Not Throw Away Your Shot: Pilot Study in Improving Medical School Curricula Through Focused Vaccine Education. AJPM Focus. 3(2). 100178–100178. 2 indexed citations
7.
Rapsinski, Glenn J., et al.. (2021). Pediatric SARS-CoV-2 seroprevalence during mitigation procedures in Southwestern Pennsylvania. SHILAP Revista de lepidopterología. 1(3). 100026–100026.
8.
Freeman, Megan Culler, et al.. (2021). Unexpected False-Positive Rates in Pediatric SARS-CoV-2 Serology Using the EUROIMMUN Anti-SARS-CoV-2 ELISA IgG Assay. American Journal of Clinical Pathology. 155(6). 773–775. 1 indexed citations
9.
Freeman, Megan Culler, et al.. (2020). Immunocompromised Seroprevalence and Course of Illness of SARS-CoV-2 in One Pediatric Quaternary Care Center. Journal of the Pediatric Infectious Diseases Society. 10(4). 426–431. 21 indexed citations
10.
Wilson, R. Paul, Sarah A. Tursi, Glenn J. Rapsinski, et al.. (2019). STAT2 dependent Type I Interferon response promotes dysbiosis and luminal expansion of the enteric pathogen Salmonella Typhimurium. PLoS Pathogens. 15(4). e1007745–e1007745. 26 indexed citations
11.
Sick-Samuels, Anna, Katherine E Goodman, Glenn J. Rapsinski, et al.. (2018). A Decision Tree Using Patient Characteristics to Predict Resistance to Commonly Used Broad-Spectrum Antibiotics in Children With Gram-Negative Bloodstream Infections. Journal of the Pediatric Infectious Diseases Society. 9(2). 142–149. 19 indexed citations
12.
Rapsinski, Glenn J., et al.. (2016). Pseudomonas mendocina native valve infective endocarditis: a case report. Journal of Medical Case Reports. 10(1). 275–275. 16 indexed citations
13.
Oppong, Gertrude O., Glenn J. Rapsinski, Sarah A. Tursi, et al.. (2015). Biofilm-associated bacterial amyloids dampen inflammation in the gut: oral treatment with curli fibres reduces the severity of hapten-induced colitis in mice. npj Biofilms and Microbiomes. 1(1). 43 indexed citations
14.
Gallo, Paul M., Glenn J. Rapsinski, R. Paul Wilson, et al.. (2015). Amyloid-DNA Composites of Bacterial Biofilms Stimulate Autoimmunity. Immunity. 42(6). 1171–1184. 174 indexed citations
15.
Gallucci, Stefania, Paul M. Gallo, Glenn J. Rapsinski, et al.. (2015). Bacterial amyloids promote type I interferon production and accelerate autoimmunity (BA6P.124). The Journal of Immunology. 194(1_Supplement). 114.5–114.5. 2 indexed citations
16.
Rapsinski, Glenn J., Meghan A. Wynosky-Dolfi, Gertrude O. Oppong, et al.. (2014). Toll-Like Receptor 2 and NLRP3 Cooperate To Recognize a Functional Bacterial Amyloid, Curli. Infection and Immunity. 83(2). 693–701. 99 indexed citations
17.
Rapsinski, Glenn J., Tiffanny Newman, Gertrude O. Oppong, Jos P. M. van Putten, & Çağla Tükel. (2013). CD14 Protein Acts as an Adaptor Molecule for the Immune Recognition of Salmonella Curli Fibers. Journal of Biological Chemistry. 288(20). 14178–14188. 47 indexed citations
18.
19.
Newman, Tiffanny, Gertrude O. Oppong, Glenn J. Rapsinski, et al.. (2012). Microbial Amyloids Induce Interleukin 17A (IL-17A) and IL-22 Responses via Toll-Like Receptor 2 Activation in the Intestinal Mucosa. Infection and Immunity. 80(12). 4398–4408. 82 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gertrude O. Oppong Breakdown of academic impact, for papers by Sarah A. Tursi Breakdown of academic impact, for papers by Azadeh Saffarian Breakdown of academic impact, for papers by Sébastien Massier Breakdown of academic impact, for papers by Mehri Zareie Breakdown of academic impact, for papers by David Prescott Breakdown of academic impact, for papers by Ulrike Dringenberg Breakdown of academic impact, for papers by Ava Behrouzi Breakdown of academic impact, for papers by Xiangyu Mou Breakdown of academic impact, for papers by Kelly Schwartz
Rankless by CCL
2026